Medical management beats stents for stroke prevention

In this large trial, patients with recent TIA or stroke and intracranial vessel stenosis of 70-99%, those randomized to medical management alone fared better than those randomized to medical management plus intracranial vessel stenting. One year rates of stroke/death were 12% versus 20%. Medical management alone will suffice for secondary stroke prevention, even in the presence of stenosis of intracranial vessels (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment